| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2026―Jun―03 |
Gut microbiota dysbiosis and Long COVID susceptibility in chronic kidney disease |
Meiling Jin, Lijie Ma, Yuqing Yuan, Kaiyi Zhu, Zhaohui Tong, Qianmei Sun |
| 2 |
[GO] |
2025―Dec―19 |
Alterations of the oral microbiome in patients reinfected with SARS-CoV-2 omicron variants |
Benchen Rao, Yongjian Zhou, Tong Ren, Hongxia Liang, Lei Li, Yakun Xu, Haiyu Wang, Xiaoping Wang, Xiaoli Ni, Xiaoning Wang, Hanmeng Liu, Xiaoli Jin, Qiaoxia Chen, Xuemei Wang, Yawen Zou, Ying Sun, Zhigang Ren, Zujiang Yu |
| 3 |
[GO] |
2025―Apr―24 |
Cover Picture: Antiviral effectiveness and safety of azvudine in hospitalized SARS-CoV-2 patients with pre-existing chronic respiratory diseases: A multicenter, retrospective cohort study (View 2/2025) |
Junyi Sun, Mengzhao Yang, Daoke Yao, Yongjian Zhou, Xiaobo Hu, Guowu Qian, Yiqiang Yuan, Silin Li, Hong Luo, Shixi Zhang, Guangming Li, Donghua Zhang, Guotao Li, Yanyang Zhang, Xinjun Hu, Zujiang Yu, Guangying Cui, Zhigang Ren |
| 4 |
[GO] |
2025―Apr―09 |
The effectiveness and safety of azvudine treatment in COVID-19 patients with kidney disease based on a multicenter retrospective cohort study |
Bo Yu, Mengzhao Yang, Jia Yu, Daming Wang, Hong Luo, Ming Cheng, Shixi Zhang, Guotao Li, Ling Wang, Guowu Qian, Donghua Zhang, Silin Li, Zhigang Ren, Quancheng Kan |
| 5 |
[GO] |
2025―Feb―06 |
Antiviral effectiveness and safety of azvudine in hospitalized SARS-CoV-2 patients with pre-existing chronic respiratory diseases: A multicenter, retrospective cohort study |
Junyi Sun, Mengzhao Yang, Daoke Yao, Yongjian Zhou, Xiaobo Hu, Guowu Qian, Yiqiang Yuan, Silin Li, Hong Luo, Shixi Zhang, Guangming Li, Donghua Zhang, Guotao Li, Yanyang Zhang, Xinjun Hu, Zujiang Yu, Guangying Cui, Zhigang Ren |
| 6 |
[GO] |
2024―Jun―19 |
Cover Picture: MALDI-TOF MS analysis of nasal swabs for the characterization of patients infected with SARS-CoV-2 Omicron (View 3/2024) |
Rui Song, Dandan Li, Xiaohua Hao, Qian Lyu, Qingwei Ma, Xiaoyou Chen, Liang Qiao |
| 7 |
[GO] |
2024―May―16 |
MALDI-TOF MS analysis of nasal swabs for the characterization of patients infected with SARS-CoV-2 Omicron |
Rui Song, Dandan Li, Xiaohua Hao, Qian Lyu, Qingwei Ma, Xiaoyou Chen, Liang Qiao |
| 8 |
[GO] |
2022―Nov―29 |
Back Cover: Wearable respiratory sensors for COVID-19 monitoring (View 5/2022) |
Guorui Chen, Sophia Shen, Trinny Tat, Xun Zhao, Yihao Zhou, Yunsheng Fang, Jun Chen |
| 9 |
[GO] |
2022―Nov―01 |
Wearable respiratory sensors for COVID-19 monitoring |
Guorui Chen, Sophia Shen, Trinny Tat, Xun Zhao, Yihao Zhou, Yunsheng Fang, Jun Chen |
| 10 |
[GO] |
2022―Jul―25 |
Back Cover: Detection, prevention and treatment of COVID-19 and opportunities for nanobiotechnology (View 4/2022) |
Qing Bao, Tao Yang, Mingying Yang, Chuanbin Mao |
| 11 |
[GO] |
2022―Jul―25 |
Cover Picture: Nanoantidote for repression of acidosis pH promoting COVID-19 infection (View 4/2022) |
Qidong Liu, Huitong Ruan, Zhihao Sheng, Xiaoru Sun, Siguang Li, Wenguo Cui, Cheng Li |
| 12 |
[GO] |
2022―Jul―20 |
Progress in COVID research and developments during pandemic |
Sudheesh K. Shukla, Santanu Patra, Trupti R. Das, Dharmesh Kumar, Anshuman Mishra, Ashutosh Tiwari |
| 13 |
[GO] |
2022―May―02 |
Nanoantidote for repression of acidosis pH promoting COVID-19 infection |
Qidong Liu, Huitong Ruan, Zhihao Sheng, Xiaoru Sun, Siguang Li, Wenguo Cui, Cheng Li |
| 14 |
[GO] |
2022―Mar―21 |
Back Cover: Therapeutic antibodies under development for SARS-CoV-2 (View 2/2022) |
Zetong Ma, MengMei Zhu, Shuyi Zhang, Kewen Qian, Chuqi Wang, Wenyan Fu, Changhai Lei, Shi Hu |
| 15 |
[GO] |
2022―Mar―15 |
Detection, prevention and treatment of COVID-19 and opportunities for nanobiotechnology |
Qing Bao, Tao Yang, Mingying Yang, Chuanbin Mao |
| 16 |
[GO] |
2022―Jan―31 |
Portable and visual assays for the detection of SARS-CoV-2 |
Yufan Zhang, Dan Ding |
| 17 |
[GO] |
2022―Jan―31 |
Inside Front Cover: Portable and visual assays for the detection of SARS-CoV-2 (View 1/2022) |
Yufan Zhang, Dan Ding |
| 18 |
[GO] |
2021―Jul―12 |
Therapeutic antibodies under development for SARS-CoV-2 |
Zetong Ma, MengMei Zhu, Shuyi Zhang, Kewen Qian, Chuqi Wang, Wenyan Fu, Changhai Lei, Shi Hu |
| 19 |
[GO] |
2021―Jun―18 |
Biodiagnostics in an era of global pandemics-From biosensing materials to data management |
Yoav Y. Broza, Hossam Haick |
| 20 |
[GO] |
2021―Jun―17 |
Frontispiece: Exosome therapeutics for COVID-19 and respiratory viruses (View 3/2021) |
Kristen D. Popowski, Phuong-Uyen C. Dinh, Arianna George, Halle Lutz, Ke Cheng |
| 21 |
[GO] |
2021―Jun―17 |
Inside Back Cover: Nano-therapeutic strategies to target coronavirus (View 3/2021) |
Mohd Ahmar Rauf, Munazzah Tasleem, Ketki Bhise, Katyayani Tatiparti, Samaresh Sau, Arun K. Iyer |
| 22 |
[GO] |
2021―May―06 |
Advances of nanomaterials-based strategies for fighting against COVID-19 |
Chunxi Zeng, Xucheng Hou, Margaret Bohmer, Yizhou Dong |
| 23 |
[GO] |
2021―Apr―08 |
Cover Picture: Applications of digital PCR in COVID-19 pandemic (View 2/2021) |
Chianru Tan, Dongdong Fan, Nan Wang, Fang Wang, Bo Wang, Lingxiang Zhu, Yong Guo |
| 24 |
[GO] |
2021―Mar―09 |
Nano-therapeutic strategies to target coronavirus |
Mohd Ahmar Rauf, Munazzah Tasleem, Ketki Bhise, Katyayani Tatiparti, Samaresh Sau, Arun K. Iyer |
| 25 |
[GO] |
2021―Jan―31 |
Exosome therapeutics for COVID-19 and respiratory viruses |
Kristen D. Popowski, Phuong-Uyen C. Dinh, Arianna George, Halle Lutz, Ke Cheng |
| 26 |
[GO] |
2021―Jan―01 |
Applications of digital PCR in COVID-19 pandemic |
Chianru Tan, Dongdong Fan, Nan Wang, Fang Wang, Bo Wang, Lingxiang Zhu, Yong Guo |
| 27 |
[GO] |
2020―Sep―25 |
Potential nanoparticle applications for prevention, diagnosis, and treatment of COVID-19 |
Sydney Kusumoputro, Shannon Tseng, Jonathan Tse, Christian Au, Candice Lau, Xiang Wang, Tian Xia |
| 28 |
[GO] |
2020―Mar―23 |
Promising methods for detection of novel coronavirus SARS-CoV-2 |
Ran Liu, Aisi Fu, Zixin Deng, Yan Li, Tiangang Liu |
|
